CAS 84367-31-7
:(R)-(+)-4-chloro 3-hydroxybutyronitrile
Formule :C5H7ClO
InChI :InChI=1/C5H7ClO/c1-2-3-5(7)4-6/h1,5,7H,3-4H2/t5-/m1/s1
Code InChI :LHBPNZDUNCZWFL-SCSAIBSYSA-N
SMILES :C#CC[C@H](CCl)O
Synonymes :- (R)-4-Cloro-3-Hydroxybutyronitrile
- (2R)-1-chloropent-4-yn-2-ol
- (R)-4-Chloro-3-hydroxybutyronitrile
- (R)-(+)-4-Chloro-3-hydroxybutyronitrile
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
7 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
(R)-(+)-4-Chloro-3-hydroxybutyronitrile
CAS :Formule :C4H6ClNODegré de pureté :>96.0%(GC)Couleur et forme :Colorless to Light yellow clear liquidMasse moléculaire :119.55(R)-4-Chloro-3-hydroxybutyronitrile
CAS :(R)-4-Chloro-3-hydroxybutyronitrileFormule :C4H6ClNODegré de pureté :>95%Masse moléculaire :119.54954(3R)-4-chloro-3-hydroxybutanenitrile
CAS :Formule :C4H6ClNODegré de pureté :97%Couleur et forme :LiquidMasse moléculaire :119.5495Levocarnitine Impurity 7
CAS :Formule :C4H6ClNOCouleur et forme :White To Off-White SolidMasse moléculaire :119.55(R)-4-Chloro-3-hydroxybutanenitrile
CAS :Formule :C4H6ClNODegré de pureté :97%Couleur et forme :LiquidMasse moléculaire :119.55(R)-4-Chloro-3-hydroxybutyronitrile
CAS :(R)-4-Chloro-3-hydroxybutyronitrile is a chiral pharmaceutical that has been shown to have hypotensive effects and hypoglycaemic properties. It is formed by the asymmetric synthesis of a ketone, utilising a synthetic route. This drug has been shown to be effective in treating cerebral infarction and other conditions related to poor blood flow. The mechanism of action of (R)-4-Chloro-3-hydroxybutyronitrile is not yet known, but it is believed that it may act as an alcohol or nutrient utiliser.Formule :C4H6ClNODegré de pureté :Min. 95%Couleur et forme :Clear LiquidMasse moléculaire :119.55 g/mol(R)-(+)-4-Chloro-3-hydroxybutyronitrile
CAS :(R)-(+)-4-Chloro-3-hydroxybutyronitrileFormule :C4H6ClNODegré de pureté :96%Masse moléculaire :119.55






